alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 11-1


                         PENNSYLVANIA ENTERPRISES, INC.

             Statement Re Computation of Per Share Earnings for the
              Twelve Month Periods Ended December 31, 1996 and 1995

[CAPTION]
                                                    Twelve Months Ended    
                                                    1996           1995    
[S]                                              [C]            [C]
Income before subsidiary's
  preferred stock dividends                      $ 8,314,000    $ 2,050,000

Subsidiary's preferred stock dividends             1,730,000      2,763,000

Net income                                       $ 6,584,000    $  (713,000)

Earnings per share of common stock (1)(2)        $       .51    $      (.06)

Computations of additional common shares
  outstanding (1)

  Average shares of common stock                  10,222,002     11,458,872

  Incremental common shares applicable to
    options, based on the daily average
    market price                                      20,684          5,208

  Average common shares as adjusted               10,242,686     11,464,080

  Average shares of common stock                  10,222,002     11,458,872 

  Incremental common shares applicable to
    options, based on the more dilutive of
    daily average or ending market price              17,634          8,190

  Average common shares fully diluted             10,239,636     11,467,062

Earnings per share of common stock (1)
  
  Average common shares as adjusted              $       .51    $      (.06)

  Average common shares fully diluted            $       .51    $      (.06)



    (1)  Restated to reflect the two-for-one split of the Company's common stock
         effective March 20, 1997.

    (2)  Reflects the effect of  premiums  totaling $1,337,012 on the redemption
         of subsidiary's preferred stock in  1996  that were charged to retained
         earnings and not included in the determination of net income.
<PAGE>
# Official Journal C 122/9 Ap

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 122 |
| | |
| English edition | Information and Notices | Volume 649 April 2021 |

ISSN 1977-091X

Official Journal

of the European Union

C 122

English edition

Information and Notices

Volume 649 April 2021

---

| Contents | page |
| --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2021/C 122/01 | Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union — Cases where the Commission raises no objections (
  1
  ) | 1 |

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2021/C 122/01

Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union — Cases where the Commission raises no objections (
  1
  )

1

1

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN
Civil Service Federal Employees Federal Employees Federal Employees

Retirement Group Life Health Benefits Retirement

System Insurance Program System

United States

Office of Personnel Management

Retirement and Insurance Service

Benefits Administration Letter

Number: 97-409 Date: October 21, 1997 

Subject: 1997 Federal Employees Health Benefits (FEHB) Program Open Season:

BlueCHOICE Health Plan 

This is to advise you that BlueCHOICE (Code 9G) serves the Illinois counties of Madison and

St. Clair as well as the St. Louis/Central/Southwest areas of Missouri. In error, the listing for

Illinois was omitted from the 1998 Guide to Federal Employees Health Benefits Plans (which

lists the plans and their premium rates). Please bring this to the attention of your employees

in Illinois. Premium rates for BlueCHOICE are the same in both Illinois and Missouri. 

Thank you for your attention to this matter.

Abby L. Block, Chief

Insurance Policy

and Information Division
NEW for 2016

You can now choose a 

Self Plus One enrollment type 

through the Federal Employees 

Health Benefits (FEHB) Program. 

The first opportunity to enroll in Self Plus One 

will be during Open Season: 

November 9, 2015 to December 14, 2015.

To enroll or change your enrollment, use your agency’s 

online enrollment system or contact your Human Resources Office. 

For more information visit: 

www.opm.gov/selfplusone

or contact:
#### DE HART v. STATE.

No. 14175.

Court of Criminal Appeals of Texas.

March 4, 1931.

Callaway & Callaway, of Brownwood, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

CHRISTIAN, J.

The offense is possession of intoxicating liquor for the purpose of sale; the punishment, confinement in the penitentiary for one year.

It is stated in the recognizance that appellant “stands charged in this court with the offense of unlawful possession of intoxicating liquors,” and that he “has been convicted in this court of the offense of unlawful possession of intoxicating liquors.” There is no such offense known to our statute. Unless appellant possessed the intoxicating liquor for the purpose of sale, his possession thereof did not offend against the laws of Texas (Rev. St. 1925, § 5075). Moore v. State, 112 Tex. Cr. R. 142, 15 S.W.(2d) 617. The recognizance is fatally defective in failing to show that appellant has been convicted of an offense. When the accused is at large, this court is without jurisdiction, in the absence of a proper recognizance or appeal bond. Moore v. State, supra, and authorities cited.

The appeal is dismissed.

PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the judges of the Court of Criminal Appeals and approved by the court.

HAWKINS, J., not sitting.
Exhibit 32.1






CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)




--------------------------------------------------------------------




In connection with the Quarterly Report of United Mines, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Glenn E. Martin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:




(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and




(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.







Registrant

Date: May 24, 2011

United Mines, Inc.

By: /s/ Glenn E. MartinGlenn E. MartinChief Executive Officer (Principal Executive Officer)
**Exhibit 32.1**

 

**CERTIFICATION OF PRESIDENT AND CHIEFFINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350**

 

In connection with this Quarterly Report of KabeExploration, Inc. (the “Company”) on Form 10-Q for the periodending September 30, 2009, as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Erik Ulsteen, President, ChiefFinancial Officer and Secretary of the Company, certifies to the best of myknowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 ofthe Sarbanes-Oxley Act of 2002, that:

 

1                  Such Quarterly Report on Form 10-Q forthe quarter ending September 30, 2009, fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Actof 1934; and

 

2                  The information contained in such Quarterly Report on Form 10-Qfor the quarter ending September 30, 2009, fairly presents, in allmaterial respects, the financial condition and results of operations of theCompany.

 
| Date: November 12, 2009 |   |
|------------------------------|--------|
| /s/  Erik Ulsteen            |   |
| Erik Ulsteen                 |   |
| President                    |   |
| Chief Financial Officer      |   |
| Secretary                    |   |

 

----
EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACTOF 2002

 

In connection with the Quarterly Report of Event Cardio Group Inc. (the"Registrant") on Form 10-Q for the quarterly period ended November 30, 2015 as filed with the Securities andExchange Commission on the date hereof (the "Report"), I, John Bentivoglio, Chief Executive Officer and actingChief Financial Officer (Principal Executive Officer and Principal Accounting Officer) of the Registrant, certify, inaccordance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

Date: January 14, 2016

John Bentivoglio

Chief ExecutiveOfficer

Acting Chief FinancialOfficer

(Principal ExecutiveOfficer and Principal Accounting Officer)
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

MICHAEL CARABALLO,

Petitioner

v.

JOSEPH H. DUPONT, ERIC TICE, S. ELLENBERGER, C. WAKEFIELD AND CAPTAIN FEAGLEY,

Respondents :

:

:

:

:

:

:

:

:

:

:

:

: No. 587 MAL 2018

Petition for Allowance of Appeal from

the Order of the Commonwealth Court

ORDER

PER CURIAM

AND NOW , this 4th day of February, 2019

, the Petition for Allowance of Appeal is

DENIED

.
**EXHIBIT 35.1**

**World Omni Financial Corp.**

**Servicer Compliance Statement**

**Pursuant to Item 1123**

**of Regulation AB**

I, Victor A. De Jesus, do hereby certify that I am the Vice President and Chief Financial Officer of World Omni Financial Corp., a Florida corporation, and further certify on behalf of World Omni Financial Corp. inits capacity as servicer (the “Servicer”) under the Sale and Servicing Agreement, dated as of July 18, 2012 (the “Agreement”), among World Omni Auto Receivables Trust 2012-A, as Issuing Entity, World Omni Auto ReceivablesLLC, as Depositor, and the Servicer, as follows: 

(i)        A review of theactivities of the Servicer during the period covered by the issuing entity’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 (the “Reporting Period”), and of its performance under the Agreement, has beenmade under my supervision. 

(ii)        To the best of my knowledge, based onthe review described above, the Servicer has fulfilled all of its obligations under the Agreement in all material respects throughout the Reporting Period. 

IN WITNESS WHEREOF, I have hereunto set my hand as of March 15, 2013.
#### LEWIS v. STATE.

No. 16209.

Court of Criminal Appeals of Texas.

Nov. 1, 1933.

John *Y.*Rust, Jr., and O. H. Tupper, Jr., both of San Angelo, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

HAWKINS, Judge.

Conviction is for robbery with firearms, punishment assessed at fifteen years in the penitentiary.

The indictment is in proper form. No statement of facts or bills of exception are found in the record. In such condition nothing is presented for review.

The judgment is affirmed.
Exhibit
32.2




CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of Cavalier Holdings, Inc. (the "Company")
on Form 10-Q for the period ending September 30 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Ajay Tandon, President
and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §
1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to
my knowledge:




(1) the
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and




(2) the
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.


Date:
      November 23, 2009
            
            /s/Ajay
  TandonAjay
      Tandon
              Director,
      President and Chief Financial Officer
              (Principal
      Financial Officer)




This
certification accompanies this Report on Form 10-Q pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by
such Act, be deemed filed by the Company for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such
certification will not be deemed to be incorporated by reference into any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except to the
extent that the Company specifically incorporates it by
reference.
| (1)   | The      Report fully complies with the requirements of section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the      Company. |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                   |   |                         |
|------------------------|--------|------------------------------|
|                   |   |                         |   |
| November      13, 2009 | By:    | /s/       Ezzie Goldish |   |
|                   |   | Ezzie      Goldish           |   |
|                   |   | Chief      Financial Officer |   |
|                   |   |                         |   |
##### 



Exhibit 99.1
 Repros Androxal Shows Highly Statistically Significant Positive Effects
in Men with Secondary Hypogonadism
 Non-Inferiority to Market Leading Drug
Demonstrated in Six Month Study
 ®
 Study Details and Results




---



##### 








---



##### 



About Repros Therapeutics Inc.
  http://www.reprosrx.com
 Any statements that are not historical facts contained in this release are forward-looking
statements that involve risks and uncertainties, including Repros ability to have success in the
clinical development of its technologies, the timing of enrollment in such clinical studies and the
accuracy of such studies, Repros ability to raise additional capital on acceptable terms or at
all, and such other risks which are identified in the Companys Annual Report on Form 10-K for the
year ended December 31, 2006, and Repros Quarterly Report on Form 10-Q for the quarter ended March
31, 2007, as they may be updated by the Companys Exchange Act filings from time to time. These
documents are available on request from Repros Therapeutics or at www.sec.gov. Repros disclaims any
intention or obligation to update or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
 Contact:
    
    Joseph S. Podolski
President & CEO
(281) 719-3447
**Exhibit
      32.1**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO SECTION 906**


**OF
      THE SARBANES-OXLEY ACT OF 2002**




In
      connection with the annual report of Belarus Capital Corp. (the "Company")
      on
      Form 10-Q for the three months ended September 30, 2008 as filed with the
      Securities and Exchange Commission on the date hereof (the "Report"), we,
      Sanford Leavitt, Chief Executive Officer, and Neil Roth, Chief Financial
      Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
      Section 906 of the Sarbanes-Oxley Act of 2002 that:




(1)
      This
      report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934, as amended; and




(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.




/s/
                Sanford Leavitt
            
            
            /s/
                Neil RothSanford
                Leavitt
              Chief
                Executive Officer
            
            
            Neil
                Roth
              Chief
                Financial OfficerDate:
                November 18, 2008
            
            
            Date:
                November 18, 2008
----

|  | (1) | the      Report fully complies with the requirements of Section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | the information contained      in the Report fairly presents, in all material respects, the financial      condition and results of operations of the  Company. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

| IMH      Financial Corporation |                         |
|--------------------------------|------------------------------|
|                           |                         |
| By:                            | /s/ Shane Albers        |   |
|                           | Shane      Albers            |   |
|                           | Chief      Executive Officer |   |
|                           |                         |   |
| By:                            | /s/ Steven      Darak        |   |
|                           | Steven      Darak            |   |
|                           | Chief      Financial Officer |   |
|                           |                         |   |
| Dated:                         | August      23, 2010         |   |

----
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3407 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 3407

To amend the Internal Revenue Code of 1986 to remove the deduction for 
   charitable contributions from the overall limitation on itemized 
                              deductions.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 29, 2015

 Mr. Sensenbrenner (for himself, Mr. Harper, and Mr. Jones) introduced 
  the following bill; which was referred to the Committee on Ways and 
                                 Means

_______________________________________________________________________

                                 A BILL

 
To amend the Internal Revenue Code of 1986 to remove the deduction for 
   charitable contributions from the overall limitation on itemized 
                              deductions.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CHARITABLE DEDUCTION EXCEPTION TO OVERALL LIMITATION ON 
              ITEMIZED DEDUCTIONS.

    (a) In General.--Subsection (c) of section 68 of the Internal 
Revenue Code of 1986 is amended by striking ``and'' at the end of 
paragraph (2), by striking the period at the end of paragraph (3) and 
inserting ``, and'', and by adding at the end the following:
            ``(4) the deduction under section 170 (relating to 
        charitable, etc., contributions and gifts).''.
    (b) Effective Date.--The amendment made by this section shall apply 
to taxable years beginning after December 31, 2014.
                                 <all>
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Transition to Independence Study Section.                    

*Date:*                         November 7-8, 2024.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         The Bethesdan Hotel, Tapestry Collection by Hilton, 8120 Wisconsin Avenue, Bethesda, MD 20814 (Hybrid Meeting).                    

*Contact Person:*                         Kazuyo Kegan, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208-T, Bethesda, MD 20892, (301) 402-1334, email:                         *kazuyo.kegan@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: October 1, 2024.

Bruce A. George, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-22983 Filed 10-3-24; 8:45 am]

BILLING CODE 4140-01-P